THALES
8.7.2021 11:02:07 CEST | Business Wire | Press release
Car manufacturers require reliable connectivity and cybersecurity solutions to bring more convenience and secure services for drivers, passengers and automotive players. To build securely connected solutions and meet the requirements of new regulations such as UNECE WP29 *, carmakers can rely on Thales. With more than 20 years’ experience in automotive connectivity and cybersecurity, Thales is supporting them in the delivery of the trusted car of the future.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210708005033/en/
To offer users a safe and pleasant driving experience, connected car need to communicate with their environment, other vehicles, road infrastructure and the car makers’ network. Thales offers a secure connectivity solution to bring drivers, passengers and maintenance teams greater access to useful information. Connectivity is provided by wireless modules that transmit and/or receive data, through specific high-speed and low latency transmission. Furthermore, the connected car can have its own digital identity thanks to an automotive-grade embedded SIM (eSIM) to identify itself on the network and verify the integrity of the data it transmits. The eSIMs also simplify logistics since the connectivity service providers can be activated after the vehicle has been manufactured or any time during its lifetime.
* UNECE WP.29 is the United Nations Economic Commission for Europe (UNECE) World Forum for the Harmonization of Vehicle Regulations
This seamless connectivity management solution enables drivers and passengers to access a variety of global in-car services, such as eCall (automatic EU emergency call in case of an accident), remote software updates and smoother recall actions.
To ensure a high degree of security, Thales supports steadfast cyber security infrastructures through advanced consulting services , strong digital authentication and encryption mechanisms. This makes it possible to protect access to the car and the data it generates or receives, send secure updates and only allow access to authorized actors during the lifetime of a vehicle. Thales Security Operation Centres (SOC) further enable car manufacturers to keep a close eye on their fleet of vehicles, secure their data, and detect and respond immediately to potential cyber threats.
“Since connecting the very first car 25 years ago, Thales has been supporting car makers in their digital transformation to build and secure connected cars. Thales benefits from strong relationships with many car manufacturers and connectivity providers, enabling a thorough understanding of current needs and the market evolution. Today we are not only able to offer the car industry innovative connectivity solutions, but also to build together the best automotive cybersecurity solutions, so people can trust and rely on their vehicles.” Christine Caviglioli, VP Automotive at Thales
“By combining the cybersecurity expertise of Thales and the connectivity solutions from our digital business, Thales is positioned as a leader on the value chain of connectivity and cybersecurity to serve the automotive industry. Our ambition is to support Tier 1 suppliers and OEMs in accelerating their secure digital transformation and path towards fully autonomous vehicles.” Jean-Marie Letort, VP Cybersecurity, Consulting & Operations at Thales
In light of this unique always-on vehicle connectivity offer, Juniper Research recently presented Thales with its “2021 Best Automotive Connectivity Solution” award.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
PLEASE VISIT
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005033/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom